Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Pelitinib [USAN:INN] View Structure
Description: An EGF receptor kinase inhibitor.

NCI: A substance being studied in the treatment of some types of cancer. It blocks the action of certain proteins that are part of the epidermal growth factor receptor (EGFR) family of proteins. These proteins may be found in increased amounts on the surface of some types of cancer cells. Blocking the action of these proteins may stop cancer cells from growing and may kill cancer cells. Pelitinib is a type of EGFR inhibitor. Also called EKB-569. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Jun 2019